CDKN2A and cancer: The reversibility of cancer cell senescence following chemotherapeutic exposure was established in the early 2000’s and was suggested to be associated with the absence of p16 function (see, e.g., landmark studies reported by Igor Roninson’s group, reviewed in [64]).